Your browser doesn't support javascript.
loading
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma.
Barsoumian, Hampartsoum B; Ramapriyan, Rishab; Younes, Ahmed I; Caetano, Mauricio S; Menon, Hari; Comeaux, Nathan I; Cushman, Taylor R; Schoenhals, Jonathan E; Cadena, Alexandra P; Reilly, Timothy P; Chen, Dawei; Masrorpour, Fatemeh; Li, Ailin; Hong, David S; Diab, Adi; Nguyen, Quynh-Nhu; Glitza, Isabella; Ferrarotto, Renata; Chun, Stephen G; Cortez, Maria Angelica; Welsh, James.
Afiliação
  • Barsoumian HB; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ramapriyan R; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Younes AI; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Caetano MS; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Menon H; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Comeaux NI; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cushman TR; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Schoenhals JE; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cadena AP; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reilly TP; Bristol-Myers Squibb Co, New York, New York, USA.
  • Chen D; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Masrorpour F; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Li A; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hong DS; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Diab A; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nguyen QN; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Glitza I; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ferrarotto R; Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chun SG; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cortez MA; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Welsh J; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA JWelsh@mdanderson.org.
J Immunother Cancer ; 8(2)2020 10.
Article em En | MEDLINE | ID: mdl-33106386
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunidade / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunidade / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article